Sumitomo Pharma Canada (SMPCA) is an innovative and entrepreneurial health care company that commercializes prescription products in Canada. We drive innovative treatments, science, and technology to address patient needs in the critical areas of psychiatry, neurology, oncology, urology, and infectious disease. We are united in our mission to deliver patient-needed therapies in Canada sooner.